SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:umu-170565"
 

Sökning: onr:"swepub:oai:DiVA.org:umu-170565" > Exogenous hormone u...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005952naa a2200985 4500
001oai:DiVA.org:umu-170565
003SwePub
008200511s2020 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:dcfd448f-f82c-40be-aee2-8c890ba65a37
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1705652 URI
0247 a https://doi.org/10.1002/ijc.326742 DOI
0247 a https://lup.lub.lu.se/record/dcfd448f-f82c-40be-aee2-8c890ba65a372 URI
040 a (SwePub)umud (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Cervenka, Irisu Institut Gustave Roussy,University of Paris-Saclay4 aut
2451 0a Exogenous hormone use and cutaneous melanoma risk in women :b The European Prospective Investigation into Cancer and Nutrition
264 c 2019-10-10
264 1b John Wiley & Sons,c 2020
338 a print2 rdacarrier
520 a Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country‐specific self‐administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992–2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline‐significant association between OC use and melanoma risk (HR = 1.12, 95% CI = 1.00–1.26), with no detected heterogeneity across countries (phomogeneity = 0.42). This risk increased linearly with duration of use (ptrend = 0.01). Among postmenopausal women, ever use of MHT was associated with a nonsignificant increase in melanoma risk overall (HR = 1.14, 95% CI = 0.97–1.43), which was heterogeneous across countries (phomogeneity = 0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a cohort studies
653 a cutaneous melanoma
653 a epidemiology
653 a hormonal treatments
653 a menopausal hormone therapy
653 a oral contraceptives
653 a cohort studies
653 a cutaneous melanoma
653 a epidemiology
653 a hormonal treatments
653 a menopausal hormone therapy
653 a oral contraceptives
7001 a Al Rahmoun, Marie4 aut
7001 a Mahamat-Saleh, Yahya4 aut
7001 a Fournier, Agnes4 aut
7001 a Boutron-Ruault, Marie-Christine4 aut
7001 a Severi, Gianluca4 aut
7001 a Caini, Saverio4 aut
7001 a Palli, Domenico4 aut
7001 a Ghiasvand, Reza4 aut
7001 a Veierod, Marit B.4 aut
7001 a Botteri, Edoardo4 aut
7001 a Tjonneland, Anne4 aut
7001 a Olsen, Anja4 aut
7001 a Fortner, Renee T.4 aut
7001 a Kaaks, Rudolf4 aut
7001 a Schulze, Matthias B.4 aut
7001 a Panico, Salvatore4 aut
7001 a Trichopoulou, Antonia4 aut
7001 a Dessinioti, Clio4 aut
7001 a Niforou, Katerina4 aut
7001 a Sieri, Sabina4 aut
7001 a Tumino, Rosario4 aut
7001 a Sacerdote, Carlotta4 aut
7001 a Bueno-de-Mesquita, Bas4 aut
7001 a Sandanger, Torkjel M.4 aut
7001 a Colorado-Yohar, Sandra4 aut
7001 a Sanchez, Maria J.4 aut
7001 a Gil Majuelo, Leire4 aut
7001 a Lujan-Barroso, Leila4 aut
7001 a Ardanaz, Eva4 aut
7001 a Merino, Susana4 aut
7001 a Isaksson, Karolinu Lund University,Lunds universitet,Lunds Melanomstudiegrupp,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Lund Melanoma Study Group,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital4 aut0 (Swepub:lu)kir-kis
7001 a Butt, Salmau Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups4 aut0 (Swepub:lu)med-smb
7001 a Ljuslinder, Ingrid4 aut
7001 a Jansson, Malinu Umeå universitet,Kirurgi4 aut0 (Swepub:umu)manjan00
7001 a Travis, Ruth C.4 aut
7001 a Khaw, Kay-Tee4 aut
7001 a Weiderpass, Elisabete4 aut
7001 a Dossus, Laure4 aut
7001 a Rinaldi, Sabina4 aut
7001 a Kvaskoff, Marinau University of Paris-Saclay,Institut Gustave Roussy4 aut
7102 a Institut Gustave Roussyb University of Paris-Saclay4 org
7102 a et al.
7730 t International Journal of Cancerd : John Wiley & Sonsg 146:12, s. 3267-3280q 146:12<3267-3280x 0020-7136x 1097-0215
8564 u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.32674
8564 u http://dx.doi.org/10.1002/ijc.32674y FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-170565
8564 8u https://doi.org/10.1002/ijc.32674
8564 8u https://lup.lub.lu.se/record/dcfd448f-f82c-40be-aee2-8c890ba65a37

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy